IACP Vice President Shawn Hodges, PharmD to Serve as Witness
for Pharmacy Compounding

The U.S. House of Representatives’ Committee on Energy & Commerce’s Subcommittee on Health will hold a hearing this morning, at 10:00 a.m. Central Time/11:00 a.m. Eastern Time in 2123 Rayburn House Office Building. The hearing is entitled, “Examining Implementation of the Compounding Quality Act.”

The International Academy of Compounding Pharmacists (IACP) has been invited to serve as a witness by the Subcommittee on Health chaired by U.S. Congressman Michael C. Burgess, MD (TX).

IACP Vice President Shawn Hodges, PharmD, will serve as a witness representing 503A compounding pharmacies. Please click here to view Shawn’s bio. On behalf of the IACP Board of Directors, we thank Shawn for his willingness and dedication to serve our profession at this hearing.

Watch Hearing Live Webcast

PLEASE NOTE: The hearing webcast will be made publicly available at

View Witness List and Background Materials

Please click here to view the complete witness list for this morning’s hearing.
IACP is working on your patients’ behalf to protect access to compounded medications! This hearing is a critical opportunity to present the value and necessity compounded medications bring to patients and the providers who serve them.

Please email IACP with questions or comments at iacpinfo@iacprx.org. We will make you aware of continuing developments.

Saving Patient Access to Life-Saving Compounded Medications is a Patient-Safety Issue!